Multi-parameter formulation development for an HIV-vaccine protein with direct validation of epitope binding integrity and stoichiometry

November 30, 2020

Popp, C., Schramm, P., Wagner, R., et al.

bioRxiv 2020, doi: 10.1101/2020.11.30.403873

Abstract

Vaccines are on the front line-of-defense against infectious diseases, ranging from threats we are familiar with, including polio, tuberculosis, or HIV, to novel and emerging threats such as SARS-CoV-2. Successful development of new protein-based vaccines requires sophisticated and efficient development of storage and formulation conditions. Here we demonstrate the combined power of 2bind’s sophisticated buffer matrix FORMOscreen® and NanoTemper Technologies’ novel Prometheus Panta high-throughput Dynamic Light Scattering/Nano Differential Scanning Fluorimetry instrument. We show that this combination can comprehensively improve critical biophysical parameters for the HIV-1 vaccine BG505-SOSIP and find the optimal formulation condition with unmatched efficiency.

View Publication

Topics: Prometheus, nanoDSF, DLS, Biologics, Publications

Previous Article
An AI-powered blood test to detect cancer using nanoDSF
An AI-powered blood test to detect cancer using nanoDSF

Up next
Saposin lipid nanoparticles: A highly versatile and modular tool for membrane protein research
Saposin lipid nanoparticles: A highly versatile and modular tool for membrane protein research

Ready to tackle your challenging stability characterizations?

Discover tools